Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
AssigneeCentre Nationale De Recherche Scientifique
InventorsYasemin Ataman-Onal, Thierry Delair, Bernard Verrier
Life of this patent
Estimating the term…
Loading patent…
AssigneeCentre Nationale De Recherche Scientifique
InventorsYasemin Ataman-Onal, Thierry Delair, Bernard Verrier
Estimating the term…
A method of vaccination against a viral, bacterial or non-infectious disease includes administering an effective dose of a prime vaccine and then an effective dose of a boost vaccine. Each one of the prime vaccine and the boost vaccine includes an active principle. The prime vaccine includes, as the active principle, a colloidal synthetic bioresorbable vector that includes at least one protein substance. The boost vaccine includes, as the active principle, a viral vector that includes at least one nucleotide sequence which codes for a protein substance corresponding to the at least one protein substance of the synthetic vector.
A method of vaccination against a viral, bacterial or non-infectious disease comprising administering an effective dose of a prime vaccine and then an effective dose of a boost vaccine, each one of the prime vaccine and the boost vaccine comprising an active principle, wherein:
Dependencies are inferred from the claim text.